Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly
2011-002158-30Phase 4Completed
- Sponsor
- Omninvest
- Start
- Jun 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Fluval AB vaccine in influenza (2 arms), sponsored by Omninvest. Primary endpoint: Immunogenicity. Started Jun 2011; status: completed.
02
Drugs
Fluval AB vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2011-002158-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002158-30.